These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9122204)

  • 1. Expression of a dominant-negative type II transforming growth factor beta (TGF-beta) receptor in the epidermis of transgenic mice blocks TGF-beta-mediated growth inhibition.
    Wang XJ; Greenhalgh DA; Bickenbach JR; Jiang A; Bundman DS; Krieg T; Derynck R; Roop DR
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2386-91. PubMed ID: 9122204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concerted action of TGF-beta 1 and its type II receptor in control of epidermal homeostasis in transgenic mice.
    Cui W; Fowlis DJ; Cousins FM; Duffie E; Bryson S; Balmain A; Akhurst RJ
    Genes Dev; 1995 Apr; 9(8):945-55. PubMed ID: 7774812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis.
    Han G; Lu SL; Li AG; He W; Corless CL; Kulesz-Martin M; Wang XJ
    J Clin Invest; 2005 Jul; 115(7):1714-23. PubMed ID: 15937546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of a dominant negative type II TGF-beta receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development.
    Amendt C; Schirmacher P; Weber H; Blessing M
    Oncogene; 1998 Jul; 17(1):25-34. PubMed ID: 9671311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking transforming growth factor beta signaling in transgenic epidermis accelerates chemical carcinogenesis: a mechanism associated with increased angiogenesis.
    Go C; Li P; Wang XJ
    Cancer Res; 1999 Jun; 59(12):2861-8. PubMed ID: 10383147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated expression of transforming growth factor beta and its type-I and type-II receptors in basal-cell carcinoma.
    Furue M; Kato M; Nakamura K; Nashiro K; Kikuchi K; Okochi H; Miyazono K; Tamaki K
    Int J Cancer; 1997 May; 71(4):505-9. PubMed ID: 9178800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis.
    Serra R; Johnson M; Filvaroff EH; LaBorde J; Sheehan DM; Derynck R; Moses HL
    J Cell Biol; 1997 Oct; 139(2):541-52. PubMed ID: 9334355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta 1 and skin carcinogenesis: antiproliferative effect in vitro and TGF-beta 1 mRNA expression during epidermal hyperproliferation and multistage tumorigenesis.
    Krieg P; Schnapke R; Fürstenberger G; Vogt I; Marks F
    Mol Carcinog; 1991; 4(2):129-37. PubMed ID: 1710462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted expression of c-Myc in the epidermis alters normal proliferation, differentiation and UV-B induced apoptosis.
    Waikel RL; Wang XJ; Roop DR
    Oncogene; 1999 Aug; 18(34):4870-8. PubMed ID: 10490820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma.
    Knaus PI; Lindemann D; DeCoteau JF; Perlman R; Yankelev H; Hille M; Kadin ME; Lodish HF
    Mol Cell Biol; 1996 Jul; 16(7):3480-9. PubMed ID: 8668164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas.
    Dominey AM; Wang XJ; King LE; Nanney LB; Gagne TA; Sellheyer K; Bundman DS; Longley MA; Rothnagel JA; Greenhalgh DA
    Cell Growth Differ; 1993 Dec; 4(12):1071-82. PubMed ID: 8117621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesis.
    Jakowlew SB; Moody TW; You L; Mariano JM
    Mol Carcinog; 1998 May; 22(1):46-56. PubMed ID: 9609100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced tumorigenesis and reduced transforming growth factor-beta type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-beta1.
    Kang Y; Mariano JM; Angdisen J; Moody TW; Diwan BA; Wakefield LM; Jakowlew SB
    Mol Carcinog; 2000 Oct; 29(2):112-26. PubMed ID: 11074608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I (RI) and type II (RII) receptors for transforming growth factor-beta isoforms are expressed subsequent to transforming growth factor-beta ligands during excisional wound repair.
    Gold LI; Sung JJ; Siebert JW; Longaker MT
    Am J Pathol; 1997 Jan; 150(1):209-22. PubMed ID: 9006337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the TGF-beta coreceptor endoglin in epidermal keratinocytes and its dual role in multistage mouse skin carcinogenesis.
    Quintanilla M; Ramirez JR; Pérez-Gómez E; Romero D; Velasco B; Letarte M; López-Novoa JM; Bernabéu C
    Oncogene; 2003 Sep; 22(38):5976-85. PubMed ID: 12955076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of transforming growth factor-beta type II receptor (TGF-betaRII) protein and mRNA expression in cervical cancer.
    Diaz-Chavez J; Hernandez-Pando R; Lambert PF; Gariglio P
    Mol Cancer; 2008 Jan; 7():3. PubMed ID: 18184435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors.
    Feng XH; Filvaroff EH; Derynck R
    J Biol Chem; 1995 Oct; 270(41):24237-45. PubMed ID: 7592630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid induction of transforming growth factors alpha and beta: modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin.
    Piazza GA; Ritter JL; Baracka CA
    Exp Cell Res; 1995 Jan; 216(1):51-64. PubMed ID: 7813633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunctional transforming growth factor-beta receptor II accelerates prostate tumorigenesis in the TRAMP mouse model.
    Pu H; Collazo J; Jones E; Gayheart D; Sakamoto S; Vogt A; Mitchell B; Kyprianou N
    Cancer Res; 2009 Sep; 69(18):7366-74. PubMed ID: 19738062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant transforming growth factor-beta signaling in azoxymethane-induced mouse colon tumors.
    Guda K; Giardina C; Nambiar P; Cui H; Rosenberg DW
    Mol Carcinog; 2001 Aug; 31(4):204-13. PubMed ID: 11536370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.